Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1987 6
1988 1
1989 1
1992 1
1993 1
1996 2
1998 1
1999 1
2000 1
2001 1
2002 1
2005 1
2007 2
2008 1
2010 2
2011 7
2012 4
2013 4
2014 3
2015 7
2016 2
2017 1
2018 6
2019 2
2020 3
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.
Pierpont ME, Brueckner M, Chung WK, Garg V, Lacro RV, McGuire AL, Mital S, Priest JR, Pu WT, Roberts A, Ware SM, Gelb BD, Russell MW; American Heart Association Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Genomic and Precision Medicine. Pierpont ME, et al. Among authors: lacro rv. Circulation. 2018 Nov 20;138(21):e653-e711. doi: 10.1161/CIR.0000000000000606. Circulation. 2018. PMID: 30571578 Free PMC article. Review.
Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2.
Zarate YA, Bosanko KA, Thomas MA, Miller DT, Cusmano-Ozog K, Martinez-Monseny A, Curry CJ, Graham JM Jr, Velsher L, Bekheirnia MR, Seidel V, Dedousis D, Mitchell AL, DiMarino AM, Riess A, Balasubramanian M, Fish JL, Caffrey AR, Fleischer N, Pierson TM, Lacro RV. Zarate YA, et al. Among authors: lacro rv. Clin Genet. 2021 Apr;99(4):547-557. doi: 10.1111/cge.13912. Epub 2021 Jan 13. Clin Genet. 2021. PMID: 33381861 Free article. Review.
New autosomal dominant branchio-oculo-facial syndrome.
Fujimoto A, Lipson M, Lacro RV, Shinno NW, Boelter WD, Jones KL, Wilson MG. Fujimoto A, et al. Among authors: lacro rv. Am J Med Genet. 1987 Aug;27(4):943-51. doi: 10.1002/ajmg.1320270422. Am J Med Genet. 1987. PMID: 3321995 Review.
Clinical approach to genetic cardiomyopathy in children.
Schwartz ML, Cox GF, Lin AE, Korson MS, Perez-Atayde A, Lacro RV, Lipshultz SE. Schwartz ML, et al. Among authors: lacro rv. Circulation. 1996 Oct 15;94(8):2021-38. doi: 10.1161/01.cir.94.8.2021. Circulation. 1996. PMID: 8873681 Review.
Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome.
Selamet Tierney ES, Levine JC, Chen S, Bradley TJ, Pearson GD, Colan SD, Sleeper LA, Campbell MJ, Cohen MS, De Backer J, Guey LT, Heydarian H, Lai WW, Lewin MB, Marcus E, Mart CR, Pignatelli RH, Printz BF, Sharkey AM, Shirali GS, Srivastava S, Lacro RV; Pediatric Heart Network Investigators. Selamet Tierney ES, et al. Among authors: lacro rv. J Am Soc Echocardiogr. 2013 Jun;26(6):657-66. doi: 10.1016/j.echo.2013.02.018. Epub 2013 Apr 10. J Am Soc Echocardiogr. 2013. PMID: 23582510 Free PMC article. Review.
Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome.
Van Driest SL, Sleeper LA, Gelb BD, Morris SA, Dietz HC, Forbus GA, Goldmuntz E, Hoskoppal A, James J, Lee TM, Levine JC, Li JS, Loeys BL, Markham LW, Meester JAN, Mital S, Mosley JD, Olson AK, Renard M, Shaffer CM, Sharkey A, Young L, Lacro RV, Roden DM. Van Driest SL, et al. Among authors: lacro rv. J Pediatr. 2020 Jul;222:213-220.e5. doi: 10.1016/j.jpeds.2020.03.064. J Pediatr. 2020. PMID: 32586526 Free PMC article. Clinical Trial.
Atenolol versus Losartan in Marfan's Syndrome.
Lacro RV, Dietz HC, Mahony L. Lacro RV, et al. N Engl J Med. 2015 Mar 5;372(10):980-1. doi: 10.1056/NEJMc1500128. N Engl J Med. 2015. PMID: 25738680 No abstract available.
60 results